Marc Salvatus

Marc Salvatus, PharmD, BCPS

Assistant Professor, Pharmacy Practice

Contact Information

Biography

Dr. Salvatus received his Bachelor of Science in Biological Sciences from the University of California, Irvine. He then earned his Doctor of Pharmacy degree from West Coast University, School of Pharmacy (WCU SOP), as a member of the inaugural class. Dr. Salvatus completed an ASHP accredited PGY1 Pharmacy Practice Residency at Adventist Health Glendale, where he obtained a post-doctorate teaching certificate through WCU SOP. His longitudinal project involved assessing the impact of a pharmacist-driven protocol to optimize antibiotic use in patients with pneumonia.

Dr. Salvatus has taught students in both the didactic and clinical settings. He is board-certified in pharmacotherapy, and he currently practices as a clinical pharmacist in an acute care community hospital where he focuses on internal medicine, antimicrobial stewardship, and transitions of care. Dr. Salvatus currently serves as a faculty advisor for the West Coast University student chapter of the American College of Clinical Pharmacy (ACCP). He strives to create an open and safe learning environment for his students and is passionate about mentoring them in their professional journey.

Publications

Yale A, Kim E, Gutierrez B, Hanamoto J, Lav N, Nourse J, Salvatus M, Hunt R, Monuki E, Flanagan L. Regulation of neural stem cell differentiation and brain development by MGAT5-mediated N-glycosylation. Stem Cell Reports. 2023;18(6):1340-1354. https://doi.org/10.1016/j.stemcr.2018.08.011

Abstract

Salvatus M, Jung H, Eskandarian R, Lee S. Impact of pharmacist-led de-escalation of MRSA therapy using MRSA nasal PCR. Open Forum Infectious Diseases. 2021;8(Supplement_1):S148-S148. https://doi.org/10.1093/ofid/ofab466.261. Accessed Jun 10, 2022.

Presentations

Salvatus M, Jung H, Eskandarian R, Lee S. Impact of pharmacist-led de-escalation of MRSA therapy using MRSA nasal PCR. Western States Conference for Pharmacy Residents, Fellows, and Preceptors. Platform Category A1 (Infectious Diseases – Anti-infective Agents), Podium Presentation #17. Virtual Conference, May 2020.

Bagheri R, Shibuyama S, Salvatus M, Lee S, Rifampin Decreases Efficacy of Warfarin: A Case Report. Poster Presentation 1, California Society of Health-System Pharmacists (CSHP) Seminar, Las Vegas, NV, October 2017.